uce
ProgressImage ProgressImage
Alkem Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 539523 border-img ISIN Demat INE540L01014 border-img Book Value 848.50 border-img NSE Symbol ALKEM border-img Div & Yield % 0.92 border-img Market Cap ( Cr.) 65029.01 border-img P/E 37.82 border-img EPS 143.82 border-img Face Value 2
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales2494.592634.592253.17
Other Operating Income0.000.000.00
Other Income 95.6661.8464.70
Total Income2590.252696.432317.87
Total Expenditure 1976.641979.991919.42
PBIDT613.61716.44398.45
Interest 21.1118.7021.42
PBDT592.50697.74377.03
Depreciation58.1259.0258.11
Tax90.46111.4853.93
Fringe Benefit Tax0.000.000.00
Deferred Tax-60.31-119.27-6.45
Reported Profit After Tax504.23646.51271.44
Extra-ordinary Items -42.620.000.00
Adjusted Profit After Extra-ordinary item546.85646.51271.44
    
EPS (Unit Curr.)42.1754.0722.70
EPS (Adj) (Unit Curr.)42.1754.0722.70
Calculated EPS (Unit Curr.)42.1854.0822.71
Calculated EPS (Adj) (Unit Curr.)42.1854.0822.71
Calculated EPS (Ann.) (Unit Curr.)168.71216.3190.82
Calculated EPS (Adj) (Ann.) (Unit Curr.)168.71216.3190.82
Book Value (Unit Curr.)0.000.000.00
Dividend (%)1750.000.000.00
Equity23.9123.9123.91
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)24.6027.1917.68
PBDTM(%)23.7526.4816.73
PATM(%)20.2124.5412.05
x
x
×
Let's Chat
close
refresh